|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-9-29
|
|
pubmed:abstractText |
The novel biomarker ST2 provides diagnostic information in a variety of clinical settings. The objective was to determine whether measurement of the soluble ST2 (sST2) concentration improves risk stratification in outpatients with decompensated heart failure (HF).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1579-2242
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1171-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20875357-Aged,
pubmed-meshheading:20875357-Area Under Curve,
pubmed-meshheading:20875357-Biological Markers,
pubmed-meshheading:20875357-Female,
pubmed-meshheading:20875357-Follow-Up Studies,
pubmed-meshheading:20875357-Heart Failure,
pubmed-meshheading:20875357-Heart Transplantation,
pubmed-meshheading:20875357-Humans,
pubmed-meshheading:20875357-Male,
pubmed-meshheading:20875357-Middle Aged,
pubmed-meshheading:20875357-Natriuretic Peptide, Brain,
pubmed-meshheading:20875357-Outpatients,
pubmed-meshheading:20875357-Peptide Fragments,
pubmed-meshheading:20875357-ROC Curve,
pubmed-meshheading:20875357-Receptors, Cell Surface,
pubmed-meshheading:20875357-Regression Analysis,
pubmed-meshheading:20875357-Risk Assessment,
pubmed-meshheading:20875357-Stroke Volume,
pubmed-meshheading:20875357-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure.
|
|
pubmed:affiliation |
Servicio de Cardiología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España. abayesgenis@gmail.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
